title: FDG-PET Evaluation of Response to Treatment.
abstract: This article discusses evaluating response after and during therapy in various settings and for the types of cancers for which ample evidence demonstrates that PET imaging with flourodeoxyglucose provides a valuable surrogate for response to therapy. It also briefly discusses pitfalls in obtaining an optimal assessment of response and issues that need further attention for this modality to become established as an independent predictor of response to anticancer therapy.
authors.affiliation: Division of Nuclear Medicine, Department of Radiology, Mount Sinai Medical Center, One Gustave Levy Place, Box: 1141, New York, NY 10029, USA. Electronic address: lale.kostakoglu@mssm.edu.
authors.forename: Lale
authors.initials: L
authors.lastname: Kostakoglu
keywords: Anticancer therapy; PET; Prediction of response; Therapy response